Dr. Garon on Immunotherapy Combinations in NSCLC – OncLive
OncLive |
Dr. Garon on Immunotherapy Combinations in NSCLC
OncLive Although the combination of immunotherapy and chemotherapy has historically been controversial in the NSCLC treatment landscape, Garon says that results from trials such as IMpower150 have begun to provide clarity. In the IMpower150 trial, patients who … |
